Get the Stockscreener App
9.87
0.30%
-0.03
After Hours:
10.10
0.23
+2.33%
Cel-Sci Corp. stock is traded at $9.87, with a volume of 54,500.
It is down -0.30% in the last 24 hours and down -3.71% over the past month.
CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company's Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.
See More
Previous Close:
$9.90
Open:
$9.72
24h Volume:
54,500
Relative Volume:
0.16
Market Cap:
$67.93M
Revenue:
-
Net Income/Loss:
$-26.92M
P/E Ratio:
-19.35
EPS:
-0.51
Net Cash Flow:
$-18.92M
1W Performance:
-3.24%
1M Performance:
-3.71%
6M Performance:
+37.60%
1Y Performance:
-66.93%
1-Day Range:
$9.6453
$10.04
1-Week Range:
$9.3665
$10.62
52-Week Range:
$1.98
$32.70
Cel-Sci Corp. Stock (CVM) Company Profile
Name
Cel-Sci Corp.
Sector
Industry
Phone
703-506-9460
Address
8229 Boone Boulevard, Suite 802, Vienna, VA
Compare CVM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVM
Cel-Sci Corp.
|
9.87 | 68.13M | 0 | -26.92M | -18.92M | -0.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-20 | Initiated | H.C. Wainwright | Buy |
| Mar-02-15 | Initiated | Dawson James | Buy |
Cel-Sci Corp. Stock (CVM) Latest News
What risks investors should watch in CEL SCI Corporation stockFed Meeting & Fast Gain Stock Tips - newser.com
How buyback programs support CEL SCI Corporation (LSR) stockJobs Report & Weekly Momentum Stock Picks - newser.com
Oct 21 9:30 a.m. PST: CEL‑SCI to Present Multikine Roadmap at LD Micro Main Event - Stock Titan
Will CEL SCI Corporation stock pay special dividendsGap Down & Free High Accuracy Swing Entry Alerts - newser.com
Will CEL SCI Corporation price bounce be sustainableChart Signals & Stepwise Swing Trade Plans - newser.com
CEL SCI Corporation stock volume spike explainedQuarterly Trade Review & Growth Focused Entry Reports - newser.com
Will Cel Sci Corporation stock gain from green policiesJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
What makes CEL SCI Corporation (LSR) stock appealing to growth investorsWeekly Trade Report & Verified Stock Trade Ideas - newser.com
Can CEL SCI Corporation (LSR) stock survive global slowdownQuarterly Profit Review & Low Drawdown Investment Ideas - newser.com
Why CEL SCI Corporation stock is a value investor pickWeekly Trade Recap & Fast Gain Swing Alerts - newser.com
Published on: 2025-10-03 01:37:57 - newser.com
Is CEL SCI Corporation stock bottoming out2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
CEL SCI Corporation stock momentum explained2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Will Cel Sci Corporation stock announce a stock splitMarket Performance Recap & Growth Focused Stock Pick Reports - newser.com
Will CEL SCI Corporation (LSR) stock split increase liquidity2025 Stock Rankings & Technical Pattern Based Signals - newser.com
CEL-SCI (NYSE:CVM) Stock Price Up 8% – Time to Buy? - Defense World
Cel-Sci Stock Slips After Public Offering: Retail's Neutral - MSN
Will CEL SCI Corporation (LSR) stock remain on Wall Street radarMarket Activity Recap & Daily Stock Trend Watchlist - newser.com
Can Cel Sci Corporation stock withstand sector downturnsWeekly Market Report & Safe Capital Preservation Plans - newser.com
What analysts say about CEL SCI Corporation stockStock Price Forecasts & Join 100,000+ Investors Already Learning - earlytimes.in
What does recent volatility data suggest for CEL SCI CorporationDay Trade & Weekly Breakout Watchlists - newser.com
Chart based analysis of CEL SCI Corporation trends2025 Short Interest & Verified Short-Term Trading Plans - newser.com
CEL-SCI Announces Pricing of $10 Million Public Offering - Investing News Network
CEL-SCI Co. (NYSE:CVM) Short Interest Down 26.3% in August - MarketBeat
Market reaction to CEL SCI Corporation’s recent newsJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
Understanding CEL SCI Corporation’s price movementMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Cel-Sci Corp. Stock (CVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):